Boston Therapeutics Inc (OTCQB:BTHE)

0.07
Delayed Data
As of Apr 18
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.12
+75.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$5.8M

Company Description

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Newton, MA.

Contact Information

Boston Therapeutics, Inc.
354 Merrimack Street No. 4
Lawrence Massachusetts 01843
P:(603) 935-9799
Investor Relations:

Employees

Shareholders

Individual stakeholders16.34%
Mutual fund holders--
Other institutional--

Top Executives

Carl W. RauschCEO, CFO, Director & Principal Accounting Officer
Loraine V. UphamChief Operating Officer